CAPZASIN HP ARTHRITIS PAIN RELIEF- capsaicin cream 
Chattem, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Capzasin HP Arthritis Pain Relief

Capzasin HP Arthritis Pain Relief

Active Ingredient

Capsaicin 0.1%

Purpose

Topical analgesic

Uses

temporarily relieves minor pain of muscles and joints associated with:

  • arthritis
  • simple backache
  • strains
  • sprains
  • bruises

Warnings

For external use only

When using this product

  • read inside of carton before using
  • use only as directed. Read and follow all directions and warnings on this carton/label. 
  • avoid contact with the eyes and mucous membranes
  • rare cases of serious burns have been reported with products of this type
  • do not bandage tightly or apply local heat (such as heating pads) or a medicated patch to the area of use
  • do not apply to wounds or damaged, broken or irritated skin
  • do not use at the same time as other topical analgesics
  • a transient burning sensation may occur upon application but generally disappears in several days
  • if severe burning occurs, discontinue use immediately and read inside carton for important information
  • do not expose the area treated with product to heat or direct sunlight
  • avoid applying into skin folds

Stop use and ask a doctor if

  • condition worsens
  • redness is present
  • irritation develops
  • symptoms persist for more than 7 days or clear up and occur again within a few days
  • you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied

If pregnant or breast-feeding

ask a health professional before use.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

adults and children over 18 years:

  • apply to affected area
  • massage into painful area until thoroughly absorbed
  • repeat as necessary, but no more than 3 to 4 times daily
  • WASH HANDS WITH SOAP AND WATER AFTER APPLYING

children 18 years or younger: ask a doctor

Inactive Ingredients

benzyl alcohol, cetyl alcohol, glyceryl stearate, isopropyl myristate, PEG-40 stearate, petrolatum, sorbitol, water (238-10)

READ INFORMATION PRINTED INSIDE CARTON BEFORE USING.

KEEP CARTON AS IT CONTAINS IMPORTANT INFORMATION.             Recyclable Carton

Dist. by Chattem, Inc., P.O. Box 2219
Chattanooga, TN 37409-0219 U.S.A.
© 2009 www.chattem.com

Principal Display Panel

Deep Penetrating       Odor Free      
HIGH POTENCY
CAPZASIN HP®
ARTHRITIS PAIN RELIEF

CAPSA
ICIN 0.1% TOPICAL ANALGESIC CREME Net wt 1.5 oz (42.5 g)

Principal Display Panel
Deep Penetrating	Odor Free	
HIGH POTENCY
CAPZASIN HP®
ARTHRITIS PAIN RELIEF
CAPSAICIN 0.1% TOPICAL ANALGESIC CREME Net wt 1.5 oz (42.5 g)

CAPZASIN HP ARTHRITIS PAIN RELIEF 
capsaicin cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:41167-7514
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CAPSAICIN (UNII: S07O44R1ZM) (CAPSAICIN - UNII:S07O44R1ZM) CAPSAICIN0.001 g  in 1 g
Inactive Ingredients
Ingredient NameStrength
BENZYL ALCOHOL (UNII: LKG8494WBH)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
PETROLATUM (UNII: 4T6H12BN9U)  
SORBITOL (UNII: 506T60A25R)  
WATER (UNII: 059QF0KO0R)  
PEG-40 MONOSTEARATE (UNII: ECU18C66Q7)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:41167-7514-21 in 1 CARTON12/01/1998
142.5 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34812/01/1998
Labeler - Chattem, Inc. (003336013)
Establishment
NameAddressID/FEIBusiness Operations
CHATTEM, INC.003336013analysis(41167-7514) , label(41167-7514) , manufacture(41167-7514) , pack(41167-7514)

Revised: 9/2023
 
Chattem, Inc.